Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 3, 2010, Pages 254-259

  Watzka, Stefan B ^a   Rauscher Pötsch, Irene ^a   Stubenberger, Elisabeth ^a   Getman, Vlad ^a   Setinek, Ulrike ^a   Tötsch, Martin ^b   Pötschger, Ulrike ^a   Müller, Michael R ^a  

^a OTTO WAGNER HOSPITAL   (Austria)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Integrin linked kinase; Non small cell lung cancer; Prognosis; Surgery

Indexed keywords

INTEGRIN LINKED KINASE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HISTOLOGY; HUMAN; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77955923601     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.02.006     Document Type: Article

References (25)

1. Burdett S., Stewart L.A., Rydzewska L. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol 2006, 1:611-621.
2. Schmidmaier R., Baumann P. ANTI-ADHESION evolves to a promising therapeutic concept in oncology. Curr Med Chem 2008, 15:978-990.
3. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
4. Adachi M., Taki T., Huang C., Higashiyama M., Doi O., Tsuji T., Miyake M. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J Clin Oncol 1998, 16:1060-1067.
5. Han J.Y., Kim H.S., Lee S.H., Park W.S., Lee J.Y., Yoo N.J. Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis. Lung Cancer 2003, 41:65-70.
6. Adachi M., Taki T., Higashiyama M., Kohno N., Inufusa H., Miyake M. Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res 2000, 6:96-101.
7. Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G., Radeva G., Filmus J., Bell J.C., Dedhar S. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 1996, 379:91-96.
8. McDonald P.C., Fielding A.B., Dedhar S. Integrin-linked kinase-essential roles in physiology and cancer biology. J Cell Sci 2008, 121:3121-3132.
9. Hannigan G., Troussard A.A., Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 2005, 5:51-63.
10. Watzka S.B., Setinek U., Huber M., Cantonati H., Lax F., Watson S., Weigel G., Muller M.R. Reactivity of integrin-linked kinase in human mesothelial cell proliferation. Interact Cardiovasc Thorac Surg 2008, 7:107-110.
11. Okamura M., Yamaji S., Nagashima Y., Nishikawa M., Yoshimoto N., Kido Y., Iemoto Y., Aoki I., Ishigatsubo Y. Prognostic value of integrin beta1-ILK-pAkt signaling pathway in non-small cell lung cancer. Hum Pathol 2007, 38:1081-1091.
12. Takanami I. Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer. BMC Cancer 2005, 5:1.
13. Liu J., Costello P.C., Pham N.A., Pintillie M., Jabali M., Sanghera J., Tsao M.S., Johnston M.R. Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model. J Thorac Oncol 2006, 1:771-779.
14. Yau C.Y., Wheeler J.J., Sutton K.L., Hedley D.W. Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res 2005, 65:1497-1504.
15. Jiang H. Overview of gefitinib in non-small cell lung cancer: an Asian perspective. Jpn J Clin Oncol 2009, 39:137-150.
16. Kaplan E. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
17. Liu E., Sinha S., Williams C., Cyrille M., Heller E., Snapper S.B., Georgopoulos K., St-Arnaud R., Force T., Dedhar S., Gerszten R.E. Targeted deletion of integrin-linked kinase reveals a role in T-cell chemotaxis and survival. Mol Cell Biol 2005, 25:11145-11155.
18. Tan C., Mui A., Dedhar S. Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-kappa B-dependent manner. J Biol Chem 2002, 277:3109-3116.
19. Yoshimi R., Yamaji S., Suzuki A., Mishima W., Okamura M., Obana T., Matsuda C., Miwa Y., Ohno S., Ishigatsubo Y. The gamma-parvin-integrin-linked kinase complex is critically involved in leukocyte-substrate interaction. J Immunol 2006, 176:3611-3624.
20. Yamaji H., Iizasa T., Koh E., Suzuki M., Otsuji M., Chang H., Motohashi S., Yokoi S., Hiroshima K., Tagawa M., Nakayama T., Fujisawa T. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother 2004, 53:786-792.
21. Lee J.G., Cho B.C., Bae M.K., Lee C.Y., Park I.K., Kim D.J., Ahn S.V., Chung K.Y. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer. Lung Cancer 2009, 63:106-110.
22. Van den Heuvel M.M., Burgers S.A., van Zandwijk N. Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination. Clin Lung Cancer 2009, 10:99-105.
23. Dwivedi A., Sala-Newby G.B., George S.J. Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening. Basic Res Cardiol 2008, 103:244-256.
24. Friedrich E.B., Clever Y.P., Wassmann S., Werner N., Bohm M., Nickenig G. Role of integrin-linked kinase in vascular smooth muscle cells: regulation by statins and angiotensin II. Biochem Biophys Res Commun 2006, 349:883-889.
25. Bibeau F., Boissiere-Michot F., Sabourin J.C., Gourgou-Bourgade S., Radal M., Penault-Llorca F., Rochaix P., Arnould L., Bralet M.P., Azria D., Ychou M. Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray. Virchows Arch 2006, 449:281-287.